CSF tau and the CSF tau/ABeta ratio for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI)

BACKGROUND: Research suggests that measurable change in cerebrospinal fluid (CSF) biomarkers occurs years in advance of the onset of clinical symptoms (Beckett 2010). In this review, we aimed to assess the ability of CSF tau biomarkers (t‐tau and p‐tau) and the CSF tau (t‐tau or p‐tau)/ABeta ratio t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cochrane Database Syst Rev
Main Authors: Ritchie, Craig, Smailagic, Nadja, Noel‐Storr, Anna H, Ukoumunne, Obioha, Ladds, Emma C, Martin, Steven
Format: Artigo
Jezik:Inglês
Izdano: John Wiley & Sons, Ltd 2017
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6464349/
https://ncbi.nlm.nih.gov/pubmed/28328043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010803.pub2
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki